Next Article in Journal
Comprehensive Assessment of Degradation Behavior of Aspirin and Atorvastatin Singly and in Combination by Using a Validated RP-HPLC Method
Previous Article in Journal
Development and Validation of a Stability-Indicating HPLC Method for the Simultaneous Determination of Sulfadiazine Sodium and Trimethoprim in Injectable Solution Formulation
 
 
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

A Novel, Validated Stability-Indicating UPLC Method for the Estimation of Lansoprazole and its Impurities in Bulk Drug and Pharmaceutical Dosage Forms

1
Dr. Reddy's Laboratories Ltd. IPDO, Bachupally, Hyderabad-500072, A.P, India
2
Department of Chemistry, J. N. T. University, Kukatpally, Hyderabad-500072, A.P, India
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2013, 81(1), 183-194; https://doi.org/10.3797/scipharm.1210-09
Submission received: 9 October 2012 / Accepted: 3 December 2012 / Published: 3 December 2012

Abstract

A novel, reversed-phase ultra-performance liquid chromatographic method was developed and validated for the determination of the assay and related substances of Lansoprazole (LAN) in bulk drug and capsule dosage forms. The related substances include degradation and process-related impurities. The method was developed using the Waters Acquity BEH C18 column and gradient program with mobile phase A as a pH 7.0 phosphate buffer and methanol in the ratio of 90: 10 (v/v), and mobile phase B as methanol and acetonitrile in the ratio of 50:50 (v/v). Lansoprazole and its impurities were monitored at 285 nm. Lansoprazole was subjected to the stress conditions of oxidative, acid, base, hydrolytic, thermal, humidity, and photolytic degradation and found to degrade significantly under acid and oxidative stress conditions. The degradation products were well-resolved from the main peak and its impurities, proving the stability-indicating power of the method. The performance of the method was validated according to the present ICH guidelines for specificity, limit of detection, limit of quantification, linearity, accuracy, precision, ruggedness, and robustness.
Keywords: Lansoprazole; Validation; UPLC; Stability indicating Lansoprazole; Validation; UPLC; Stability indicating

Share and Cite

MDPI and ACS Style

RAO, P.V.; KUMAR, M.N.; KUMAR, M.R. A Novel, Validated Stability-Indicating UPLC Method for the Estimation of Lansoprazole and its Impurities in Bulk Drug and Pharmaceutical Dosage Forms. Sci. Pharm. 2013, 81, 183-194. https://doi.org/10.3797/scipharm.1210-09

AMA Style

RAO PV, KUMAR MN, KUMAR MR. A Novel, Validated Stability-Indicating UPLC Method for the Estimation of Lansoprazole and its Impurities in Bulk Drug and Pharmaceutical Dosage Forms. Scientia Pharmaceutica. 2013; 81(1):183-194. https://doi.org/10.3797/scipharm.1210-09

Chicago/Turabian Style

RAO, Papanaboina VENKATA, Morrisetty NAGENDRA KUMAR, and Maram RAVI KUMAR. 2013. "A Novel, Validated Stability-Indicating UPLC Method for the Estimation of Lansoprazole and its Impurities in Bulk Drug and Pharmaceutical Dosage Forms" Scientia Pharmaceutica 81, no. 1: 183-194. https://doi.org/10.3797/scipharm.1210-09

Article Metrics

Back to TopTop